Larry R. Degen

    Chief Accounting Officer and Secretary

    Larry R. Degen joined MGC Diagnostics in 2010 as Corporate Controller. Mr. Degen has held leadership roles with the company including Interim Chief Financial Officer and most recently as the Company’s principal accounting officer and secretary. Prior to his most recent role, Mr. Degen worked with Micro Dynamics Corporation (dba Logic) as Chief Financial Officer where he was responsible for executive management and oversight of financial and human resources operations. Prior to Logic, Mr. Degen was Corporate Controller, and ultimately,  Vice President and Principal Accounting Officer of Pemstar, Inc., an international contract manufacturing company and engineering services firm. Prior to Pemstar, he was employed by Capital Safety Company, Ltd, a safety products manufacturer, as Chief Financial Officer, and at Palaru Corporation, a commercial printer, as Chief Financial Officer. Mr. Degen was also employed by Ernst & Young for 15 years, where he served primarily manufacturing clients in audit and special project support services. Mr. Degen holds a Bachelor of Arts, in Accounting and Business Administration/Economics from St. John’s University in Collegeville, Minnesota.

    Jill Burchill

    Interim Chief Financial Officer

    Ms. Burchill has over 30 years of experience as a financial professional, including serving as chief financial officer or interim chief financial officer for a number of public and private issuers.

    Matthew S. Margolies

    President

    Matthew Margolies has a career in the healthcare industry spanning 20 years. Mr. Margolies comes to MGC Diagnostics from Cardinal Health, where he served as Senior Vice President of Sales and Marketing of the company’s Nuclear Pharmacy team. Prior to his most recent role, Mr. Margolies worked with CardioNet as Senior Vice President of Sales and Marketing generating substantial growth in CardioNet’s Cardiac Telemetry business. Prior to CardioNet, Mr. Margolies served for four years in a number of positions of increasing responsibility with VIASYS Healthcare, where he ultimately became Division President for the Respiratory Diagnostics group leading the company’s Worldwide Respiratory Diagnostics team. In his role with VIASYS he was responsible for the growth in the Respiratory Diagnostics space that was a component of the $1.6 billion acquisition of VIASYS by Cardinal Health (now CareFusion). From 1993-2004, Mr. Margolies held Sales and Marketing leadership roles with Covidien Health / Mallinckrodt Imaging. Mr. Margolies holds a bachelor’s degree in Business Administration/Marketing from Ramapo College of New Jersey.



    Todd M. Austin

    Chief Executive Officer

    Todd Austin has a career spanning 20 years and is a globally recognized clinical and medical device industry expert and leader with extensive experience in product development and marketing, strategic planning, business development, P&L responsibility, and clinical consulting. In recent years Mr. Austin has provided clinical, strategic and tactical consulting services to senior management for a number of domestic and international healthcare companies, including MGC Diagnostics.

    From 2006 to 2010 Mr. Austin was Director of Marketing for CareFusion, a leading, global corporation serving the health care industry with products and services that help hospitals measurably improve safety and quality of care. Prior to CareFusion Mr. Austin served as Vice President – U.S. Sales and Marketing for ndd Medical Technologies, a Zurich, Switzerland-based company. Mr. Austin also served as Group Product Manager for Yorba Linda, California-based VIASYS Healthcare and Customer/Product Support and Applications Manager for SensorMedics Corporation. Mr. Austin holds a Bachelor of Science degree from Mount Marty College.







    © 2012-2017 MGC Diagnostics Corporation. All Rights Reserved. Privacy Policy | Terms of Use
    MGC Diagnostics and its affiliates are equal opportunity/affirmative action employers committed to cultural diversity in the workplace and complies with Executive Orders 11246 and 13496 and hereby provides notice of its compliance with FAR 52-222-26, 29 CFR Part 471, Appendix A to Subpart A, 41 C.F.R. 60-1.4, 41 C.F.R. 60-250.5, and 41 C.F.R. 60-741.5.